 Robert Batey
Concepts (431)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Riboswitch | 35 | 2023 | 58 | 15.100 |
Why?
| | Nucleic Acid Conformation | 61 | 2023 | 670 | 6.900 |
Why?
| | RNA, Bacterial | 28 | 2023 | 175 | 6.590 |
Why?
| | RNA | 31 | 2023 | 833 | 5.420 |
Why?
| | Aptamers, Nucleotide | 22 | 2020 | 74 | 4.150 |
Why?
| | Vitamin B 12 | 7 | 2023 | 115 | 3.370 |
Why?
| | RNA Folding | 8 | 2023 | 32 | 3.240 |
Why?
| | Bacillus subtilis | 12 | 2020 | 61 | 3.200 |
Why?
| | Models, Molecular | 36 | 2020 | 1435 | 3.130 |
Why?
| | S-Adenosylmethionine | 12 | 2017 | 49 | 3.010 |
Why?
| | Ligands | 32 | 2023 | 567 | 2.900 |
Why?
| | Purines | 11 | 2019 | 161 | 2.860 |
Why?
| | Base Sequence | 40 | 2023 | 2159 | 2.830 |
Why?
| | Crystallography, X-Ray | 26 | 2022 | 422 | 2.610 |
Why?
| | 5' Untranslated Regions | 10 | 2014 | 52 | 2.420 |
Why?
| | Gene Expression Regulation, Bacterial | 10 | 2022 | 279 | 2.270 |
Why?
| | RNA, Messenger | 17 | 2016 | 2657 | 2.210 |
Why?
| | Transcription, Genetic | 11 | 2020 | 1323 | 1.920 |
Why?
| | Binding Sites | 27 | 2023 | 1224 | 1.750 |
Why?
| | Gene Expression Regulation | 12 | 2020 | 2445 | 1.580 |
Why?
| | Bacterial Proteins | 9 | 2020 | 759 | 1.530 |
Why?
| | RNA, Catalytic | 8 | 2020 | 182 | 1.430 |
Why?
| | Adenine | 7 | 2020 | 223 | 1.410 |
Why?
| | Molecular Sequence Data | 25 | 2015 | 2871 | 1.320 |
Why?
| | Regulatory Sequences, Ribonucleic Acid | 6 | 2007 | 18 | 1.290 |
Why?
| | Biosensing Techniques | 2 | 2020 | 107 | 1.230 |
Why?
| | Flavin Mononucleotide | 2 | 2018 | 8 | 1.080 |
Why?
| | Deoxyguanosine | 2 | 2019 | 23 | 1.060 |
Why?
| | Tetrahydrofolates | 3 | 2015 | 11 | 1.040 |
Why?
| | Escherichia coli | 10 | 2020 | 758 | 1.010 |
Why?
| | Genetic Engineering | 3 | 2014 | 83 | 1.000 |
Why?
| | Introns | 4 | 2014 | 234 | 0.930 |
Why?
| | Biochemical Phenomena | 1 | 2023 | 10 | 0.930 |
Why?
| | Guanine | 6 | 2011 | 75 | 0.910 |
Why?
| | HMGB Proteins | 1 | 2023 | 15 | 0.900 |
Why?
| | Bacteria | 4 | 2022 | 757 | 0.890 |
Why?
| | CRISPR-Cas Systems | 2 | 2020 | 85 | 0.870 |
Why?
| | Protein Binding | 16 | 2023 | 1975 | 0.860 |
Why?
| | Escherichia coli K12 | 1 | 2020 | 7 | 0.780 |
Why?
| | CRISPR-Associated Proteins | 1 | 2020 | 1 | 0.780 |
Why?
| | Base Pairing | 11 | 2020 | 59 | 0.780 |
Why?
| | Models, Genetic | 3 | 2020 | 595 | 0.770 |
Why?
| | Protein Biosynthesis | 3 | 2016 | 397 | 0.770 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 1 | 2020 | 18 | 0.770 |
Why?
| | Enzyme Assays | 1 | 2020 | 23 | 0.770 |
Why?
| | Ribosomal Proteins | 6 | 2006 | 68 | 0.760 |
Why?
| | Lysine | 3 | 2012 | 248 | 0.750 |
Why?
| | Chromatography, Affinity | 3 | 2009 | 85 | 0.740 |
Why?
| | Endodeoxyribonucleases | 1 | 2020 | 60 | 0.740 |
Why?
| | SOXB1 Transcription Factors | 1 | 2020 | 61 | 0.720 |
Why?
| | Thermodynamics | 12 | 2014 | 392 | 0.710 |
Why?
| | Gene Editing | 1 | 2020 | 63 | 0.700 |
Why?
| | RNA-Binding Proteins | 6 | 2023 | 371 | 0.700 |
Why?
| | Magnesium | 7 | 2015 | 150 | 0.690 |
Why?
| | Signal Recognition Particle | 5 | 2007 | 8 | 0.660 |
Why?
| | RNA, Long Noncoding | 4 | 2022 | 161 | 0.650 |
Why?
| | Quinoxalines | 1 | 2018 | 62 | 0.640 |
Why?
| | Archaeal Proteins | 2 | 2009 | 49 | 0.620 |
Why?
| | Dihydroxyphenylalanine | 1 | 2017 | 7 | 0.600 |
Why?
| | 5-Hydroxytryptophan | 1 | 2017 | 22 | 0.600 |
Why?
| | Cobamides | 1 | 2017 | 18 | 0.590 |
Why?
| | Ribosomes | 3 | 2006 | 142 | 0.590 |
Why?
| | Receptors, Glucocorticoid | 3 | 2023 | 133 | 0.590 |
Why?
| | Synthetic Biology | 2 | 2014 | 10 | 0.590 |
Why?
| | Mutation | 9 | 2017 | 3457 | 0.570 |
Why?
| | Crystallization | 6 | 2019 | 146 | 0.570 |
Why?
| | Coenzymes | 1 | 2016 | 20 | 0.560 |
Why?
| | Kinetics | 9 | 2017 | 1624 | 0.560 |
Why?
| | Small Molecule Libraries | 1 | 2017 | 80 | 0.560 |
Why?
| | Cyanobacteria | 1 | 2017 | 62 | 0.560 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 409 | 0.550 |
Why?
| | Calorimetry | 3 | 2012 | 59 | 0.550 |
Why?
| | X-Ray Diffraction | 1 | 2016 | 86 | 0.550 |
Why?
| | Conserved Sequence | 8 | 2017 | 219 | 0.540 |
Why?
| | Chemical Fractionation | 1 | 2014 | 29 | 0.490 |
Why?
| | Folic Acid Antagonists | 1 | 2014 | 8 | 0.490 |
Why?
| | Thermotoga maritima | 3 | 2009 | 10 | 0.480 |
Why?
| | S-Adenosylhomocysteine | 2 | 2010 | 21 | 0.480 |
Why?
| | DNA | 6 | 2023 | 1388 | 0.480 |
Why?
| | Ribonucleotides | 5 | 2017 | 26 | 0.460 |
Why?
| | Purine Nucleotides | 1 | 2013 | 11 | 0.460 |
Why?
| | Static Electricity | 5 | 2020 | 121 | 0.440 |
Why?
| | Ribonucleoproteins | 3 | 2020 | 88 | 0.430 |
Why?
| | Streptococcus mutans | 1 | 2011 | 8 | 0.410 |
Why?
| | Substrate Specificity | 5 | 2018 | 371 | 0.410 |
Why?
| | Gene Regulatory Networks | 1 | 2013 | 239 | 0.400 |
Why?
| | RNA, Ribosomal, 16S | 4 | 1999 | 514 | 0.390 |
Why?
| | RNA, Archaeal | 2 | 2009 | 13 | 0.380 |
Why?
| | Mouse Embryonic Stem Cells | 2 | 2020 | 25 | 0.370 |
Why?
| | DNA-Binding Proteins | 4 | 2023 | 1346 | 0.370 |
Why?
| | Pyrococcus horikoshii | 1 | 2009 | 4 | 0.350 |
Why?
| | Ribonucleoproteins, Small Nuclear | 1 | 2009 | 23 | 0.350 |
Why?
| | Anti-Bacterial Agents | 2 | 2018 | 1510 | 0.340 |
Why?
| | Molecular Structure | 4 | 2018 | 459 | 0.340 |
Why?
| | Transcription Factors | 5 | 2023 | 1570 | 0.340 |
Why?
| | Geobacillus stearothermophilus | 3 | 1998 | 12 | 0.330 |
Why?
| | Ethanol | 5 | 2000 | 575 | 0.330 |
Why?
| | Models, Chemical | 3 | 2008 | 274 | 0.330 |
Why?
| | Genes, Reporter | 2 | 2020 | 270 | 0.330 |
Why?
| | Proteobacteria | 1 | 2008 | 17 | 0.320 |
Why?
| | Hydrogen Bonding | 5 | 2012 | 146 | 0.320 |
Why?
| | Gene Expression | 5 | 2014 | 1489 | 0.320 |
Why?
| | Fluorescent Dyes | 2 | 2020 | 316 | 0.310 |
Why?
| | Tumor Necrosis Factor-alpha | 5 | 2000 | 1171 | 0.300 |
Why?
| | Genes, Switch | 1 | 2006 | 7 | 0.300 |
Why?
| | Ribonucleoproteins, Small Nucleolar | 1 | 2006 | 3 | 0.290 |
Why?
| | RNA, Small Nucleolar | 1 | 2006 | 8 | 0.290 |
Why?
| | Thermoanaerobacter | 1 | 2006 | 1 | 0.290 |
Why?
| | Pyrimidines | 2 | 2006 | 382 | 0.290 |
Why?
| | Protein Structure, Secondary | 4 | 2011 | 338 | 0.280 |
Why?
| | Methyltransferases | 1 | 2006 | 61 | 0.280 |
Why?
| | SELEX Aptamer Technique | 1 | 2005 | 14 | 0.270 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2006 | 84 | 0.270 |
Why?
| | Telomerase | 1 | 2008 | 207 | 0.270 |
Why?
| | Isotope Labeling | 2 | 1996 | 76 | 0.270 |
Why?
| | Magnetic Resonance Spectroscopy | 5 | 2004 | 508 | 0.270 |
Why?
| | Mutagenesis | 2 | 2020 | 176 | 0.270 |
Why?
| | Binding, Competitive | 3 | 2020 | 205 | 0.260 |
Why?
| | Hypoxanthine | 1 | 2004 | 11 | 0.260 |
Why?
| | Dexamethasone | 2 | 2023 | 320 | 0.250 |
Why?
| | Protein Domains | 3 | 2020 | 212 | 0.240 |
Why?
| | Structure-Activity Relationship | 3 | 2018 | 522 | 0.240 |
Why?
| | Liver | 5 | 1998 | 1816 | 0.240 |
Why?
| | Alcohol Dehydrogenase | 2 | 1994 | 22 | 0.240 |
Why?
| | X Chromosome Inactivation | 2 | 2020 | 21 | 0.230 |
Why?
| | Animals | 22 | 2020 | 33381 | 0.230 |
Why?
| | Phylogeny | 4 | 2014 | 816 | 0.230 |
Why?
| | Escherichia coli Proteins | 3 | 2007 | 170 | 0.230 |
Why?
| | RNA, Viral | 2 | 2020 | 572 | 0.230 |
Why?
| | Leucovorin | 2 | 2014 | 43 | 0.220 |
Why?
| | RNA, Protozoan | 2 | 2004 | 58 | 0.220 |
Why?
| | Protein Structure, Tertiary | 5 | 2009 | 823 | 0.220 |
Why?
| | Iridium | 2 | 2016 | 6 | 0.220 |
Why?
| | Sequence Deletion | 2 | 2020 | 171 | 0.210 |
Why?
| | Cobalt | 2 | 2016 | 48 | 0.210 |
Why?
| | Estrogen Receptor alpha | 1 | 2022 | 126 | 0.200 |
Why?
| | RNA, Ribosomal | 2 | 2003 | 158 | 0.200 |
Why?
| | Cations | 3 | 2016 | 79 | 0.200 |
Why?
| | Leptotrichia | 1 | 2020 | 1 | 0.200 |
Why?
| | Rats, Wistar | 8 | 2000 | 399 | 0.190 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2020 | 5 | 0.190 |
Why?
| | Liver Diseases, Alcoholic | 2 | 2000 | 87 | 0.190 |
Why?
| | Terminator Regions, Genetic | 2 | 2011 | 12 | 0.190 |
Why?
| | Molecular Conformation | 3 | 2014 | 146 | 0.190 |
Why?
| | Hepatitis, Animal | 1 | 2000 | 2 | 0.190 |
Why?
| | Nucleotide Motifs | 1 | 2020 | 31 | 0.190 |
Why?
| | Drugs, Chinese Herbal | 1 | 2000 | 14 | 0.190 |
Why?
| | X Chromosome | 1 | 2020 | 47 | 0.190 |
Why?
| | Recombinant Proteins | 3 | 2017 | 1308 | 0.190 |
Why?
| | Endogenous Retroviruses | 1 | 2020 | 19 | 0.180 |
Why?
| | Rifampin | 1 | 2020 | 69 | 0.180 |
Why?
| | Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2020 | 25 | 0.180 |
Why?
| | Theophylline | 1 | 2020 | 60 | 0.180 |
Why?
| | Gram-Negative Aerobic Bacteria | 2 | 1996 | 5 | 0.180 |
Why?
| | Liver Cirrhosis, Alcoholic | 2 | 1998 | 19 | 0.180 |
Why?
| | Nitrogen Isotopes | 2 | 1996 | 55 | 0.170 |
Why?
| | Point Mutation | 2 | 2011 | 228 | 0.170 |
Why?
| | Aminoimidazole Carboxamide | 2 | 2017 | 11 | 0.170 |
Why?
| | Evolution, Molecular | 3 | 2014 | 454 | 0.170 |
Why?
| | Carbon Isotopes | 2 | 1996 | 115 | 0.170 |
Why?
| | Cloning, Molecular | 1 | 2020 | 546 | 0.170 |
Why?
| | Fluorescence | 2 | 2018 | 159 | 0.160 |
Why?
| | Models, Biological | 4 | 2017 | 1715 | 0.160 |
Why?
| | 2-Aminopurine | 2 | 2009 | 10 | 0.160 |
Why?
| | Genes, Bacterial | 3 | 2009 | 162 | 0.160 |
Why?
| | Transcriptome | 1 | 2023 | 756 | 0.160 |
Why?
| | Polymerase Chain Reaction | 4 | 2009 | 1012 | 0.160 |
Why?
| | Intrinsically Disordered Proteins | 1 | 2017 | 15 | 0.150 |
Why?
| | Drug Design | 1 | 2018 | 160 | 0.150 |
Why?
| | Aquatic Organisms | 1 | 2017 | 9 | 0.150 |
Why?
| | Endotoxemia | 1 | 1998 | 93 | 0.150 |
Why?
| | Temperature | 3 | 2008 | 622 | 0.150 |
Why?
| | Deuterium | 1 | 1996 | 78 | 0.140 |
Why?
| | Microscopy, Fluorescence | 1 | 2018 | 412 | 0.140 |
Why?
| | Affinity Labels | 2 | 2007 | 26 | 0.140 |
Why?
| | Intubation, Gastrointestinal | 1 | 1996 | 61 | 0.140 |
Why?
| | Salts | 1 | 2016 | 39 | 0.140 |
Why?
| | Nucleotides | 1 | 1996 | 112 | 0.140 |
Why?
| | Helicobacter pylori | 3 | 2000 | 31 | 0.140 |
Why?
| | Species Specificity | 1 | 2017 | 565 | 0.140 |
Why?
| | MicroRNAs | 1 | 2022 | 637 | 0.140 |
Why?
| | Viral Proteins | 3 | 2009 | 296 | 0.130 |
Why?
| | Gastrostomy | 1 | 1996 | 93 | 0.130 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2000 | 984 | 0.130 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2009 | 536 | 0.130 |
Why?
| | Genetic Variation | 1 | 2020 | 926 | 0.130 |
Why?
| | Humans | 23 | 2023 | 118972 | 0.130 |
Why?
| | Rats | 9 | 2000 | 5392 | 0.130 |
Why?
| | Monocytes | 1 | 1998 | 513 | 0.130 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2014 | 155 | 0.130 |
Why?
| | Protein Engineering | 1 | 2016 | 107 | 0.130 |
Why?
| | Hydroxocobalamin | 1 | 2014 | 26 | 0.120 |
Why?
| | Protein Conformation | 3 | 2004 | 848 | 0.120 |
Why?
| | T-Lymphocytes | 5 | 2000 | 1774 | 0.120 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 1995 | 136 | 0.120 |
Why?
| | Interleukin-1 | 2 | 1998 | 980 | 0.120 |
Why?
| | Transcription Termination, Genetic | 1 | 2014 | 11 | 0.120 |
Why?
| | Molecular Docking Simulation | 1 | 2014 | 101 | 0.120 |
Why?
| | Plasmids | 2 | 2018 | 355 | 0.120 |
Why?
| | RNA Stability | 1 | 2014 | 97 | 0.110 |
Why?
| | RNA, Transfer | 1 | 2014 | 119 | 0.110 |
Why?
| | Hepatitis B | 1 | 1993 | 52 | 0.110 |
Why?
| | Fatty Liver | 1 | 1995 | 253 | 0.110 |
Why?
| | Concanavalin A | 4 | 2000 | 74 | 0.110 |
Why?
| | HIV Long Terminal Repeat | 1 | 1992 | 7 | 0.110 |
Why?
| | Cytoplasm | 1 | 1993 | 269 | 0.110 |
Why?
| | Methotrexate | 1 | 2014 | 227 | 0.110 |
Why?
| | Tetrahymena thermophila | 2 | 2004 | 59 | 0.110 |
Why?
| | Cytoskeleton | 1 | 1993 | 181 | 0.110 |
Why?
| | Dietary Carbohydrates | 1 | 1993 | 153 | 0.110 |
Why?
| | Guanosine Triphosphate | 2 | 2004 | 87 | 0.100 |
Why?
| | Interleukin-6 | 4 | 2000 | 688 | 0.100 |
Why?
| | Fusobacterium nucleatum | 1 | 2011 | 3 | 0.100 |
Why?
| | Operator Regions, Genetic | 1 | 1991 | 6 | 0.100 |
Why?
| | Mice | 5 | 2020 | 15520 | 0.100 |
Why?
| | Alcohol Drinking | 2 | 1995 | 652 | 0.100 |
Why?
| | Potassium Chloride | 1 | 1991 | 41 | 0.100 |
Why?
| | Drug Discovery | 1 | 2012 | 124 | 0.100 |
Why?
| | Amino Acid Sequence | 2 | 2009 | 2071 | 0.100 |
Why?
| | Bacteriophage lambda | 1 | 1991 | 81 | 0.100 |
Why?
| | Scattering, Small Angle | 1 | 2010 | 20 | 0.100 |
Why?
| | Crystallography | 1 | 2010 | 25 | 0.100 |
Why?
| | Folic Acid | 1 | 2011 | 161 | 0.090 |
Why?
| | Duodenum | 3 | 1996 | 67 | 0.090 |
Why?
| | Replication Protein A | 1 | 2009 | 11 | 0.090 |
Why?
| | Adenosine | 2 | 2009 | 211 | 0.090 |
Why?
| | Clostridium botulinum | 1 | 2009 | 4 | 0.090 |
Why?
| | Gastritis | 2 | 2000 | 82 | 0.090 |
Why?
| | Central Nervous System Depressants | 2 | 2000 | 89 | 0.090 |
Why?
| | Schizosaccharomyces pombe Proteins | 1 | 2009 | 42 | 0.090 |
Why?
| | Titrimetry | 1 | 2009 | 9 | 0.090 |
Why?
| | DNA, Viral | 1 | 1991 | 356 | 0.090 |
Why?
| | Nucleic Acid Denaturation | 1 | 2009 | 30 | 0.090 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 332 | 0.080 |
Why?
| | Open Reading Frames | 1 | 2009 | 121 | 0.080 |
Why?
| | Glucocorticoids | 2 | 2023 | 545 | 0.080 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 2009 | 52 | 0.080 |
Why?
| | 3' Untranslated Regions | 1 | 2009 | 142 | 0.080 |
Why?
| | DNA, Bacterial | 2 | 2008 | 314 | 0.080 |
Why?
| | Telomere-Binding Proteins | 1 | 2009 | 87 | 0.080 |
Why?
| | Exons | 1 | 2009 | 307 | 0.080 |
Why?
| | Protein Interaction Mapping | 1 | 2009 | 104 | 0.080 |
Why?
| | Sequence Alignment | 1 | 2009 | 336 | 0.080 |
Why?
| | ortho-Aminobenzoates | 1 | 2008 | 7 | 0.080 |
Why?
| | Lipopolysaccharides | 4 | 2000 | 870 | 0.080 |
Why?
| | Anhydrides | 1 | 2008 | 18 | 0.080 |
Why?
| | Repressor Proteins | 1 | 1991 | 377 | 0.080 |
Why?
| | DNA Mutational Analysis | 1 | 2009 | 381 | 0.080 |
Why?
| | Telomere | 1 | 2009 | 204 | 0.080 |
Why?
| | History, 21st Century | 1 | 2008 | 170 | 0.070 |
Why?
| | Nucleic Acids | 1 | 2008 | 59 | 0.070 |
Why?
| | Base Pair Mismatch | 1 | 2006 | 15 | 0.070 |
Why?
| | Azoarcus | 1 | 2006 | 1 | 0.070 |
Why?
| | Interleukin-2 | 2 | 2001 | 416 | 0.070 |
Why?
| | History, 20th Century | 1 | 2008 | 281 | 0.070 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2006 | 76 | 0.070 |
Why?
| | Female | 19 | 2020 | 61564 | 0.070 |
Why?
| | Alternative Splicing | 1 | 2008 | 193 | 0.070 |
Why?
| | Thiamine Pyrophosphate | 1 | 2006 | 1 | 0.070 |
Why?
| | Sulfur | 1 | 2006 | 44 | 0.070 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2009 | 348 | 0.070 |
Why?
| | Methylation | 1 | 2006 | 204 | 0.070 |
Why?
| | Methionine | 1 | 2006 | 145 | 0.070 |
Why?
| | Cell Cycle Proteins | 1 | 2009 | 565 | 0.070 |
Why?
| | HEK293 Cells | 2 | 2018 | 625 | 0.070 |
Why?
| | Alanine Transaminase | 3 | 2000 | 152 | 0.060 |
Why?
| | Operon | 1 | 2004 | 62 | 0.060 |
Why?
| | Time Factors | 3 | 2009 | 6412 | 0.060 |
Why?
| | Methanococcus | 1 | 2004 | 9 | 0.060 |
Why?
| | Microscopy, Electron | 2 | 1995 | 413 | 0.060 |
Why?
| | Lymphocyte Activation | 2 | 1998 | 1067 | 0.060 |
Why?
| | Helicobacter Infections | 2 | 2000 | 25 | 0.060 |
Why?
| | Membrane Transport Proteins | 1 | 2004 | 136 | 0.060 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 195 | 0.050 |
Why?
| | Fluorescence Resonance Energy Transfer | 2 | 2014 | 183 | 0.050 |
Why?
| | Enterocytes | 1 | 2001 | 15 | 0.050 |
Why?
| | Antigens, Bacterial | 2 | 2000 | 116 | 0.050 |
Why?
| | Male | 7 | 2020 | 57801 | 0.050 |
Why?
| | Cell Membrane Permeability | 1 | 2001 | 88 | 0.050 |
Why?
| | Transcriptional Activation | 1 | 2023 | 348 | 0.050 |
Why?
| | RNA, Untranslated | 1 | 2022 | 115 | 0.050 |
Why?
| | RNA Splicing | 1 | 2022 | 243 | 0.050 |
Why?
| | Endopeptidases | 1 | 2001 | 73 | 0.050 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2001 | 146 | 0.050 |
Why?
| | Dosage Compensation, Genetic | 1 | 2020 | 9 | 0.050 |
Why?
| | Transformation, Bacterial | 1 | 2000 | 5 | 0.050 |
Why?
| | Hepatitis, Alcoholic | 1 | 1999 | 13 | 0.040 |
Why?
| | Potassium | 1 | 2000 | 132 | 0.040 |
Why?
| | Chromatin | 1 | 2023 | 441 | 0.040 |
Why?
| | Interferon-gamma | 2 | 2000 | 736 | 0.040 |
Why?
| | RNA, Small Nuclear | 1 | 2018 | 32 | 0.040 |
Why?
| | Liver Cirrhosis, Experimental | 1 | 1998 | 11 | 0.040 |
Why?
| | Color | 1 | 2018 | 76 | 0.040 |
Why?
| | Kupffer Cells | 1 | 1998 | 47 | 0.040 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein U | 1 | 2017 | 2 | 0.040 |
Why?
| | Tetrahymena | 1 | 1998 | 156 | 0.040 |
Why?
| | RNA-Binding Protein FUS | 1 | 2017 | 12 | 0.040 |
Why?
| | G-Quadruplexes | 1 | 2017 | 15 | 0.040 |
Why?
| | Cell Nucleus | 1 | 2020 | 580 | 0.040 |
Why?
| | Host-Pathogen Interactions | 1 | 2020 | 300 | 0.040 |
Why?
| | Dinucleoside Phosphates | 1 | 2017 | 22 | 0.040 |
Why?
| | Diethyl Pyrocarbonate | 1 | 1996 | 2 | 0.040 |
Why?
| | Fragile X Mental Retardation Protein | 1 | 2017 | 65 | 0.040 |
Why?
| | Ethylnitrosourea | 1 | 1996 | 10 | 0.040 |
Why?
| | Cell Line | 2 | 2020 | 2707 | 0.040 |
Why?
| | Gastroscopy | 1 | 1996 | 17 | 0.040 |
Why?
| | Thionucleotides | 1 | 1996 | 34 | 0.040 |
Why?
| | Water | 1 | 2000 | 425 | 0.040 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 1998 | 240 | 0.040 |
Why?
| | HeLa Cells | 1 | 2018 | 583 | 0.040 |
Why?
| | Endoribonucleases | 1 | 2017 | 64 | 0.040 |
Why?
| | Oligoribonucleotides | 1 | 1996 | 52 | 0.040 |
Why?
| | Protein Folding | 1 | 1998 | 250 | 0.040 |
Why?
| | Hydrazines | 1 | 1996 | 31 | 0.040 |
Why?
| | Glutamine | 1 | 2017 | 88 | 0.040 |
Why?
| | Iodine | 1 | 1996 | 19 | 0.040 |
Why?
| | Green Fluorescent Proteins | 1 | 2018 | 395 | 0.040 |
Why?
| | New South Wales | 2 | 1993 | 10 | 0.040 |
Why?
| | Cell Membrane | 1 | 2000 | 710 | 0.030 |
Why?
| | Antibiotic Prophylaxis | 1 | 1996 | 100 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 1996 | 363 | 0.030 |
Why?
| | Deoxyribonucleotides | 1 | 1995 | 17 | 0.030 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 1996 | 224 | 0.030 |
Why?
| | Enteral Nutrition | 1 | 1996 | 170 | 0.030 |
Why?
| | Craniocerebral Trauma | 1 | 1996 | 146 | 0.030 |
Why?
| | Culture Media | 1 | 1995 | 163 | 0.030 |
Why?
| | Hydrolysis | 1 | 1995 | 176 | 0.030 |
Why?
| | Tissue Embedding | 1 | 1993 | 3 | 0.030 |
Why?
| | Hepatitis B Core Antigens | 1 | 1993 | 5 | 0.030 |
Why?
| | Hepatitis B Antibodies | 1 | 1993 | 10 | 0.030 |
Why?
| | Hepatitis B Surface Antigens | 1 | 1993 | 19 | 0.030 |
Why?
| | Surgical Wound Infection | 1 | 1996 | 251 | 0.030 |
Why?
| | Killer Cells, Lymphokine-Activated | 1 | 1993 | 9 | 0.030 |
Why?
| | Hepatitis B virus | 1 | 1993 | 25 | 0.030 |
Why?
| | Antigens, Differentiation, T-Lymphocyte | 1 | 1993 | 83 | 0.030 |
Why?
| | Glucose Solution, Hypertonic | 1 | 1993 | 1 | 0.030 |
Why?
| | Urban Health | 1 | 1993 | 78 | 0.030 |
Why?
| | Nervous System Diseases | 1 | 1996 | 261 | 0.030 |
Why?
| | Seroepidemiologic Studies | 1 | 1993 | 146 | 0.030 |
Why?
| | Injections, Intraperitoneal | 1 | 1993 | 108 | 0.030 |
Why?
| | Metabolic Clearance Rate | 1 | 1993 | 113 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 1995 | 490 | 0.030 |
Why?
| | Methylococcaceae | 1 | 1992 | 2 | 0.030 |
Why?
| | Cell Division | 3 | 2001 | 776 | 0.030 |
Why?
| | Middle Aged | 7 | 2000 | 27617 | 0.030 |
Why?
| | Cytokines | 3 | 1996 | 1900 | 0.030 |
Why?
| | Autoradiography | 1 | 1991 | 72 | 0.030 |
Why?
| | Viral Regulatory and Accessory Proteins | 1 | 1991 | 28 | 0.030 |
Why?
| | DNA Fingerprinting | 1 | 1991 | 26 | 0.030 |
Why?
| | Electrochemistry | 1 | 1991 | 69 | 0.030 |
Why?
| | Fructose | 1 | 1993 | 204 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2018 | 2851 | 0.020 |
Why?
| | Antigens, CD | 1 | 1993 | 460 | 0.020 |
Why?
| | Aged, 80 and over | 3 | 2000 | 6561 | 0.020 |
Why?
| | Urease | 2 | 2000 | 9 | 0.020 |
Why?
| | Heroin Dependence | 1 | 1989 | 19 | 0.020 |
Why?
| | Chloride Channels | 2 | 2001 | 35 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2009 | 200 | 0.020 |
Why?
| | Case-Control Studies | 1 | 1996 | 3171 | 0.020 |
Why?
| | Methadone | 1 | 1989 | 69 | 0.020 |
Why?
| | Polyethylene Glycols | 1 | 1993 | 578 | 0.020 |
Why?
| | Lymphocyte Count | 2 | 1998 | 136 | 0.020 |
Why?
| | Phosphorylation | 1 | 1992 | 1633 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2000 | 827 | 0.020 |
Why?
| | Prevalence | 1 | 1993 | 2326 | 0.020 |
Why?
| | Computer Simulation | 1 | 2011 | 922 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 1995 | 3730 | 0.020 |
Why?
| | Aged | 4 | 2000 | 19657 | 0.020 |
Why?
| | Ambulatory Care | 1 | 1989 | 482 | 0.020 |
Why?
| | Adult | 6 | 2000 | 31512 | 0.020 |
Why?
| | Pregnancy Complications | 1 | 1989 | 448 | 0.020 |
Why?
| | Blood Glucose | 1 | 1993 | 1939 | 0.010 |
Why?
| | Immunohistochemistry | 2 | 1998 | 1691 | 0.010 |
Why?
| | Cells, Cultured | 2 | 2001 | 4077 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 1993 | 4552 | 0.010 |
Why?
| | Treatment Outcome | 1 | 1996 | 9342 | 0.010 |
Why?
| | Xanthine | 1 | 2001 | 8 | 0.010 |
Why?
| | Thymidine | 1 | 2001 | 62 | 0.010 |
Why?
| | Colforsin | 1 | 2001 | 55 | 0.010 |
Why?
| | Mannitol | 1 | 2001 | 34 | 0.010 |
Why?
| | Receptors, Interleukin-2 | 1 | 2001 | 65 | 0.010 |
Why?
| | RNA Probes | 1 | 2001 | 14 | 0.010 |
Why?
| | Hepatitis Delta Virus | 1 | 2001 | 6 | 0.010 |
Why?
| | RNA, Ribosomal, 23S | 1 | 2001 | 12 | 0.010 |
Why?
| | Dyspepsia | 1 | 2000 | 9 | 0.010 |
Why?
| | Cyclic AMP | 1 | 2001 | 242 | 0.010 |
Why?
| | Blood Cells | 1 | 2000 | 39 | 0.010 |
Why?
| | Gastric Mucosa | 1 | 2000 | 45 | 0.010 |
Why?
| | Intestine, Small | 1 | 2001 | 131 | 0.010 |
Why?
| | CD4 Antigens | 1 | 2000 | 126 | 0.010 |
Why?
| | Mitogens | 1 | 1999 | 57 | 0.010 |
Why?
| | Interleukin-4 | 1 | 2000 | 215 | 0.010 |
Why?
| | Interleukin-8 | 1 | 2000 | 249 | 0.010 |
Why?
| | Retrospective Studies | 1 | 1996 | 12978 | 0.010 |
Why?
| | Immunoglobulin A | 1 | 2000 | 174 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 982 | 0.010 |
Why?
| | Lymphocyte Subsets | 1 | 1998 | 76 | 0.010 |
Why?
| | Endotoxins | 1 | 1999 | 234 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2001 | 1293 | 0.010 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2001 | 288 | 0.010 |
Why?
| | Disaccharidases | 1 | 1996 | 2 | 0.010 |
Why?
| | Ion Transport | 1 | 1996 | 60 | 0.010 |
Why?
| | Immunoglobulin G | 1 | 2000 | 788 | 0.010 |
Why?
| | Mucins | 1 | 1996 | 59 | 0.010 |
Why?
| | Keratins | 1 | 1996 | 174 | 0.010 |
Why?
| | Immunoblotting | 1 | 1996 | 307 | 0.010 |
Why?
| | T-Lymphocyte Subsets | 1 | 1998 | 396 | 0.010 |
Why?
| | Epithelium | 1 | 1996 | 305 | 0.010 |
Why?
| | Cycloheximide | 1 | 1994 | 57 | 0.010 |
Why?
| | DNA Probes | 1 | 1994 | 60 | 0.010 |
Why?
| | Chronic Disease | 1 | 2000 | 1636 | 0.010 |
Why?
| | Child | 1 | 1993 | 19129 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2000 | 1284 | 0.010 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1994 | 143 | 0.010 |
Why?
| | CD56 Antigen | 1 | 1993 | 34 | 0.010 |
Why?
| | Receptors, IgG | 1 | 1993 | 67 | 0.010 |
Why?
| | Cell Adhesion Molecules | 1 | 1994 | 180 | 0.010 |
Why?
| | CD3 Complex | 1 | 1993 | 92 | 0.010 |
Why?
| | DNA Primers | 1 | 1994 | 533 | 0.010 |
Why?
| | Immunoenzyme Techniques | 1 | 1993 | 195 | 0.010 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 1998 | 702 | 0.010 |
Why?
| | Cytotoxicity, Immunologic | 1 | 1993 | 204 | 0.010 |
Why?
| | Interleukins | 1 | 1994 | 242 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 1994 | 1094 | 0.010 |
Why?
| | Epithelial Cells | 1 | 1996 | 963 | 0.010 |
Why?
| | Apoptosis | 1 | 1999 | 2484 | 0.010 |
Why?
| | Fibroblasts | 1 | 1994 | 842 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1989 | 182 | 0.010 |
Why?
| | Intestinal Mucosa | 1 | 1993 | 531 | 0.010 |
Why?
| | Prospective Studies | 1 | 1989 | 6471 | 0.000 |
Why?
| | Pregnancy | 1 | 1989 | 5690 | 0.000 |
Why?
|
|
Batey's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|